San Francisco—Inpatient palliative care improves quality of life (QOL), symptom burden, depression and anxiety in patients with hematologic malignancies undergoing hematopoietic cell transplantation (HCT), according to results from a randomized trial.
The study, reported at the 2016 Palliative Care in Oncology Symposium (abstract 103), is the first to show the benefits of palliative care in patients with hematologic malignancies undergoing curative therapy, according to the lead